ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,021 | -25.0% | 14,281 | -40.5% | 0.07% | -11.8% |
| Q2 2023 | $9,358 | -20.1% | 24,012 | -23.6% | 0.08% | -21.6% |
| Q1 2023 | $11,710 | +77.3% | 31,429 | +80.3% | 0.10% | +1.0% |
| Q4 2022 | $6,604 | -99.8% | 17,433 | +62.6% | 0.10% | +95.9% |
| Q3 2022 | $3,785,000 | -42.4% | 10,721 | -38.2% | 0.05% | -39.5% |
| Q2 2022 | $6,574,000 | +1106.2% | 17,351 | +776.8% | 0.08% | +912.5% |
| Q1 2021 | $545,000 | -86.7% | 1,979 | -89.1% | 0.01% | -92.5% |
| Q2 2020 | $4,100,000 | – | 18,205 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |